D70.1
Agranulocytosis secondary to cancer chemotherapy
Billable
Code Hierarchy
D70D70.1
Coding Guidelines
Use Additional Code
- code for adverse effect, if applicable, to identify drug (T45.1X5)
Code Also
- underlying neoplasm
Get started with Scope today
Spend more time caring for patients, not charting. Scope captures your patient encounters in real time and quickly generates high-quality clinical notes – and it's completely free.
1k+
from 1k+ happy clinicians